Can the Seattle Heart Failure Model Be Used to Risk-stratify Heart Failure Patients for Potential Left Ventricular Assist Device Therapy?

This publication has 24 references indexed in Scilit:

• Discordance Between Patient-Predicted and Model-Predicted Life Expectancy Among Ambulatory Patients With Heart Failure
  JAMA, 2008
• Use of a Continuous-Flow Device in Patients Awaiting Heart Transplantation
  New England Journal of Medicine, 2007
• Validation of the Seattle Heart Failure Model in a Community-Based Heart Failure Population and Enhancement by Adding B-Type Natriuretic Peptide
  The American Journal of Cardiology, 2007
• Effects of Cardiac Resynchronization Therapy With or Without a Defibrillator on Survival and Hospitalizations in Patients With New York Heart Association Class IV Heart Failure
  Circulation, 2007
• Candidate Selection for Long-term Left Ventricular Assist Device Therapy for Refractory Heart Failure
  The Journal of Heart and Lung Transplantation, 2006
• The Seattle Heart Failure Model
  Circulation, 2006
• ACC/AHA 2005 Guideline Update for the Diagnosis and Management of Chronic Heart Failure in the Adult
  Journal of the American College of Cardiology, 2005
• Peak Oxygen Consumption as a Predictor of Death in Patients With Heart Failure Receiving β-Blockers
  Circulation, 2005
• A prognostic model for predicting waiting-list mortality for a total national cohort of adult heart-transplant candidates
  Transplantation, 2003
• Long-Term Use of a Left Ventricular Assist Device for End-Stage Heart Failure
  New England Journal of Medicine, 2001